BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20681763)

  • 1. Primary use of sirolimus-eluting stents in the infrapopliteal arteries.
    Rastan A; Schwarzwälder U; Noory E; Taieb FH; Beschorner U; Sixt S; Bürgelin K; Amantea P; Neumann FJ; Zeller T
    J Endovasc Ther; 2010 Aug; 17(4):480-7. PubMed ID: 20681763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia: long-term clinical and angiographic follow-up.
    Werner M; Schmidt A; Freyer M; Bausback Y; Bräunlich S; Friedenberger J; Schuster J; Botsios S; Scheinert D; Ulrich M
    J Endovasc Ther; 2012 Feb; 19(1):12-9. PubMed ID: 22313195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: infrapopliteal angioplasty with drug-eluting stents: from heart to toe.
    Siablis D; Katsanos K; Karnabatidis D
    J Endovasc Ther; 2010 Aug; 17(4):488-91. PubMed ID: 20681764
    [No Abstract]   [Full Text] [Related]  

  • 4. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.
    Goltz JP; Ritter CO; Kellersmann R; Klein D; Hahn D; Kickuth R
    J Endovasc Ther; 2012 Jun; 19(3):450-6. PubMed ID: 22788900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia.
    Karnabatidis D; Spiliopoulos S; Diamantopoulos A; Katsanos K; Kagadis GC; Kakkos S; Siablis D
    J Endovasc Ther; 2011 Feb; 18(1):1-12. PubMed ID: 21314342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents.
    Balzer JO; Zeller T; Rastan A; Sixt S; Vogl TJ; Lehnert T; Khan V
    J Cardiovasc Surg (Torino); 2010 Apr; 51(2):183-91. PubMed ID: 20354488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease.
    Bosiers M; Scheinert D; Peeters P; Torsello G; Zeller T; Deloose K; Schmidt A; Tessarek J; Vinck E; Schwartz LB
    J Vasc Surg; 2012 Feb; 55(2):390-8. PubMed ID: 22169682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial.
    Rastan A; Tepe G; Krankenberg H; Zahorsky R; Beschorner U; Noory E; Sixt S; Schwarz T; Brechtel K; Böhme C; Neumann FJ; Zeller T
    Eur Heart J; 2011 Sep; 32(18):2274-81. PubMed ID: 21622669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Below-knee bare nitinol stent placement in high-risk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice.
    Donas KP; Schwindt A; Schönefeld T; Tessarek J; Torsello G
    Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):688-93. PubMed ID: 19328021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit.
    Siablis D; Karnabatidis D; Katsanos K; Kagadis GC; Kraniotis P; Diamantopoulos A; Tsolakis J
    J Endovasc Ther; 2007 Apr; 14(2):241-50. PubMed ID: 17484536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.
    Giaquinta A; Vincenzo A; De Marco E; Veroux M; Veroux P
    Vasc Endovascular Surg; 2017 Feb; 51(2):60-66. PubMed ID: 28100126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifurcation stenting after failed angioplasty of infrapopliteal arteries in critical limb ischemia: techniques and short-term follow-up.
    Werner M; Scheinert S; Bausback Y; Bräunlich S; Ulrich M; Piorkowski M; Scheinert D; Schmidt A
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E522-8. PubMed ID: 23404942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the cryoplasty technique in the treatment of infrapopliteal lesions for Critical Limb Ischemia patients in a routine hospital setting: one-year outcome of the Cryoplasty CLIMB Registry.
    Bosiers M; Deloose K; Vermassen F; Schroë H; Lauwers G; Lansinck W; Peeters P
    J Cardiovasc Surg (Torino); 2010 Apr; 51(2):193-202. PubMed ID: 20354489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia.
    Kickuth R; Keo HH; Triller J; Ludwig K; Do DD
    J Vasc Interv Radiol; 2007 Jun; 18(6):703-8. PubMed ID: 17538131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMMIT registry: one-year outcomes after implantation of the EPIC self-expanding nitinol stent in the femoropopliteal segment.
    Werner M; Piorkowski M; Thieme M; Nanning T; Beschorner U; Rastan A; Zeller T; Scheinert D
    J Endovasc Ther; 2013 Dec; 20(6):759-66. PubMed ID: 24325691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease.
    Lammer J; Bosiers M; Zeller T; Schillinger M; Boone E; Zaugg MJ; Verta P; Peng L; Gao X; Schwartz LB
    J Vasc Surg; 2011 Aug; 54(2):394-401. PubMed ID: 21658885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes following primary drug-eluting stenting of infrapopliteal bifurcations.
    Spiliopoulos S; Fragkos G; Katsanos K; Diamantopoulos A; Karnabatidis D; Siablis D
    J Endovasc Ther; 2012 Dec; 19(6):788-96. PubMed ID: 23210878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up.
    Donas KP; Torsello G; Schwindt A; Schönefeld E; Boldt O; Pitoulias GA
    J Vasc Surg; 2010 Aug; 52(2):356-61. PubMed ID: 20541349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.